Company plans Phase 2 trial in first-recurrence head & neck cancer, in combination with immune checkpoint...
GeoVax to Host Conference Call at 4:30 PM ET ATLANTA, GA, July 30, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.